Xu Liang
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 31, 2025
Al 18 F-NOTA-HER2-BCH Versus 18 F-FDG PET/CT for Detecting Bone Metastases : Sensitivity and Quantitative Comparison.Xiaoyi Guo, Jiayue Liu, Huan Ma
|Jul 16, 2025
Real-world outcomes of first-line treatment with HLX02 versus reference trastuzumab plus pertuzumab in HER2-positive metastatic breast cancer.Ying Yan, Ruyan Zhang, Yanling Li
|Jun 30, 2025
Phase I trial of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumors.Yu Jiang, Xu Liang, Mei-Li Sun
|Jan 10, 2024
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis.Xu Liang, Linhui Zhang, Xinyu Gui
|Aug 17, 2023
Long-term Outcome Analysis of Pyrotinib in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: A Real-World Study.Xu Liang, Xinyu Gui, Ying Yan
|Jul 05, 2023
Effectiveness, safety, and impact on quality of life of eribulin-based therapy in heavily pretreated patients with metastatic breast cancer: A real-world analysis.Xinyu Gui, Xu Liang, Huiping Li
Pageof 1
